Clinical Trial Update: Named Patient Program With Rotigotine Transdermal System

View source ↗

Summary

This document reports an update on the named patient program for the rotigotine transdermal system, noting that the program has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine | Status: COMPLETED